Xinzeyuan Medical Technology Co., Ltd, a Hangzhou-based micro invasive medical device supply chain platform, has reportedly secured over RMB 100 million (USD 13.8 million) in a Series B financing round. The round was led by Qiming Venture Partners, with Silicon Paradise also participating in the funding. The company plans to channel the proceeds towards upstream core technology research and development, as well as manufacturing and base construction.
Established in 2015, Xinzeyuan Medtech has expanded its business to encompass over 30,000 types of minimally invasive medical components and more than 3,600 types of components. The company’s global reach extends to more than 20 countries and regions, positioning it as a significant player in the micro invasive medical device market.- Flcube.com
